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Abstract
Background
Long-term success of HIV antiretroviral therapy requires near-perfect adherence, main-
tained throughout one’s lifetime. However, perceptions towards ART and patterns of adher-
ence may change during the life course. We assessed challenges to long-term adherence in
adolescents and adults in three regional HIV treatment centers in Uganda.
Methods
We conducted 24 in-depth interviews and 2 focus group discussions with a total of 33
health-care providers and expert clients (HIV patients on long-term ART who assist with
adherence support of fellow patients). Interview topics included experiences with patients
on long-term treatment with either declining adherence or persistent poor adherence. Tran-
scribed texts were coded and analyzed based on the social-ecological framework highlight-
ing differences and commonalities between adolescents and adults.
Results
The overarching themes in adolescents were unstructured treatment holidays, delays in dis-
closure of HIV status by caretakers, stigma, which was mainly experienced in boarding
schools, and diminishing or lack of clinical support. In particular, there was minimal support
for early and gradual disclosure for caretakers to the infected children, diminishing clinical
support for young adults during transition to adult-based care and declining peer-to-peer
support group activities. The predominating theme in adults was challenges with treatment
access among temporary economic migrants. Common themes to adults and adolescents
were challenges with disclosure in intimate relationships, treatment related factors including
side effects, supply of single tablets in place of fixed-dose combined drugs, supply of drug
brands with unfavorable taste and missed opportunities for counseling due to shortage of
staff.
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Conclusion
Adherence counseling and support should be adapted differently for adolescents and adults
and to the emerging life course challenges in long-term treated patients. Programs should
also address constraints experienced by temporary economic migrants to ensure continuity
of treatment within the host country.
Introduction
Unprecedented scale-up of antiretroviral treatment (ART) in sub-Saharan Africa has remark-
ably changed the face of HIV epidemic from the previous fatal illness to a life-long chronic
disease [1]. Subsequent sustenance of long-term and successful treatment outcomes depends
primarily on achieving sustained viral suppression, supported by optimum life-long adherence
[2]. Remarkably high levels of adherence have been reported in sub-Saharan Africa in compari-
son to western countries [3], but these findings contrast with those from other studies reporting
increasing levels of patients with treatment failure [4,5], low retention [6] and high mortality
rates [7]. Fewer studies have assessed adherence in long-term treated patients, despite the grow-
ing numbers as ART programs mature in the region [8–10].
Adherence over time may decline with duration of treatment [11,12] improve [8] or stabilize
[13]. The reasons for decline in long-term treated patients may vary from those at the initial
treatment phase [10,14]. As patient’s health improve, change in perception towards the disease,
laxity to medication restrictions such as alcohol and tobacco use, non-disclosures in new sexual
relationships and other life-course events may influence adherence to medication [10,14].
Of particular importance to long-term adherence is the emerging cohort of perinatally HIV
infected children who are increasingly surviving into adolescence and adulthood. In 2014,
about 2 million adolescents (aged 10–19) were living with HIV-AIDS (ALWHA), with 1.2 mil-
lion (61%) in Eastern and Southern Africa [15]. ART adherence in ALWHA in sub-Saharan
Africa is reported to be lower as compared to other age groups [16–18] including children
[17,18] and declines also with increasing age [16,18]. Subsequently, adolescents have compara-
tively poor treatment responses [16,19] including high mortality [15,16].
Few studies have assessed long-term adherence among adolescents and young adults in
sub-Saharan Africa [16,17,20–23]. A recent study in Uganda reported stigma, discrimination,
attending rural health facilities and disclosure issues as main barriers to adherence [20]. Peer
support groups, counseling, supportive health care workers, short waiting time, provision of
food and transport were facilitators. More contextual data is needed to guide sustenance of
long-term treatment adherence in this group. Although health-care workers play a pivotal role
in providing adherence support and are thus usually more informed through their interactions
with the patients and their understanding of the health-care system, few studies have included
them when assessing adherence.
To conceptualize the barriers and facilitators to long-term ART adherence in both adoles-
cents and adults, we conducted a qualitative study with health care workers and expert clients
from three regional referral HIV treatment centers in Uganda.
Methods
Theoretical approach
This descriptive qualitative study draws from the social-ecological model (SEM) framework,
which considers an individual’s behavior in this case ‘ART adherence’ as being a result of
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dynamic and complex interactions of factors at the various social-ecological levels in which the
individual is situated [24]. An individual’s behavior is hence shaped based on the information,
influence and interactions he/she obtains within one’s social-networks, social environment
and institutions.
In sub-Saharan Africa, this includes cultural aspects, religious and society beliefs on the
cause of the disease and its management [25]. In this way the construes of adherence do not
only include the “how to adhere” as guided by the medication aspects and the “why to adhere”
based on individual aspects but also the social component which influences the willingness
and ability to adhere[25]. Indeed whether a person will adhere to treatment in such settings is
heavily grounded in the social context and an individual must not only negotiate the how’s
and why’s of adherence but also the societal positive and negative influences.
Moreover the individual is also dependent on the resources available to assist him/her to
access and adhere to treatment [25–27]. In this way adherence to medication does not simply
depends on the individual’s behavior but also upon structural factors within the individual
social and environmental context.
In addition to social and structural factors, a patient’s adherence behavior is also influenced
by program level factors. This includes such aspects as availability of drugs, distance and trans-
port costs to ART clinics, quality of care, relationship with caregiver, as well as treatment fac-
tors such as dosing complexities[25–27].
Setting
The study was conducted in three regional referral centers (RRCs) in Uganda; the Joint Clinical
Research Center (JCRC) in Kampala and the RRCs in Fort Portal and Mbale, both run by the
MOH. JCRC Kampala provides care to approximately 15,000 clients, 2,000 of whom are HIV-
infected children and adolescents. RRC Mbale has approximately 4,200 patients on ART, with
400 children and adolescents; and RRC Fort Portal has approximately 7,474 patients, with
approximately 500 children and adolescents. Ethical approval for this study was received from
the Hospital Clinic-University of Barcelona Ethical Committee Board, the Joint Clinical Research
Center ethical review board and the Uganda National Council for Science and Technology.
Data collection
Data collection took place from May to August 2015, using semi-structured interviews (n = 24)
with open-ended probes and focused group discussion (n = 2). We recruited participants
based on purposive sampling so as to include more informative persons with regard to long-
term adherence. In particular we included health-care workers who had longer years of experi-
ence with patients (Table 1), those specifically handling adolescents and adolescents transition-
ing to adult-based care (transitioners). We also included expert clients including adolescents
themselves. Expert clients are HIV+ patients on long-term ART who assist the health-care
workers mainly with adherence support of fellow patients. They play a vital role in bridging the
gap caused by a limited health-care workforce but more important are able to reach out to
patients at a more personal level based on their own experiences with the disease and treatment
[28,29]. They provide counseling, motivate fellow patients by sharing their own personal expe-
riences, conduct active tracing of patients lost-to-follow-up, offer adherence support and
sometimes also assist health-care workers in minor clinical work such as in triage, patient flow
and translation [28,29].
Data collection guidelines were designed to elicit health-care providers’ and expert clients’
views on declining adherence after long-term treatment and persistent poor adherence. Specif-
ically the interview guides were set to elicit personal experiences of the health-care workers
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with poor-adherent patients and included the reasons given for the non-adherence as well as
the management of these patients. The guides were also developed in such a way as to elicit
broader aspects within the social-ecological framework, including personal-related barriers,
social, and institutional-related barriers. In this way, the interviews provided deeper insights of
both health-care workers personal experience with the clients as well as the broader systemic
challenges known to impact on adherence. The guides were also adapted to gather the personal
experiences of expert patients with ART adherence.
Through the study the guides were also progressively adapted within a cyclic research design
where data gathered and analysed informed the next interviews. The iterative process was con-
tinued until saturation. Interviews were conducted at the clinic setting and lasted on average
for 60–120 minutes. All the interviews were conducted in English by SCI; a junior research sci-
entist-MSc, with close support from MR; a senior social scientist-PhD. All participants were
provided with a detailed description of the study including the consent process and verbal con-
sent was obtained and tape-recorded before each interview took place. The use of verbal con-
sent was approved by the JCRC ethical review committee and was based on minimal risks
associated with the study. All interviews were transcribed verbatim. Random fragments were
sampled for quality checks and the data was imported and analyzed using the qualitative soft-
ware package NVivo v.10.0 (QSR International). We employed a framework approach to ana-
lyze the data. We specifically used the social-ecological framework to create an initial coding
guide that was also designed to highlight differences between adolescents and adults. This was
done through discussions between SCI and MR. SCI then coded all the transcripts while MR
checked the coded outputs. Codes were then revised and refined based on relevant and recur-
rent themes emerging from the data. Relationship codes were then created to analyze linkages
and memos employed to document emerging themes. We then developed matrices to organize
and iteratively compare the data indicating differences and commonalities between adoles-
cents and adults.
Results
A total of 33 individuals participated in this study including eleven nurses, nine adherence
counselors, five medical doctors, five expert clients and three pharmacists (Table 1). Of these
24 participated in the interviews and 17 in the focus group discussions.
Eight key themes regarding long-term adherence were identified from the data, four of
which were predominant among the adolescents; unstructured treatment holidays, delays in
Table 1. Characteristics of study participants.
Total participants In-depth interview -N FGDs-N
Doctors 5 2
Nurses 11 6
Pharmacists 3 2
Counselors 9 6
Expert clients 5 1
Characteristics N
Years of experience with ART care and treatment (Median, IQR) 7 (2–23) 7 (4–8)
Female/male gender 22/11 14/3
Site N N
Joint clinical research center, 23 8
Mbale regional referral center 7 _
Fort Portal regional referral center 3 7
doi:10.1371/journal.pone.0167492.t001
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disclosure of HIV status to perinatally infected adolescents, stigma in boarding schools, and
diminishing or lack of family and clinic support (extent that the clinic staff/structure helps the
patient to adhere). In adults, challenge with treatment access among temporary economic
migrants was the predominating theme. Common themes to adolescents and adults included
disclosure in intimate relationships, treatment related factors and missed opportunities for
counseling due to shortage of staff.
Barriers specific to adolescents
Individual-level factors. Unstructured treatment holidays were noted amongst adoles-
cents and were expressed as a desire to experience a drug-free life or a quest to understand the
effects of being off drugs. However this was also as a result of underlying factors that included
drug fatigue, pill burden, depression and stigma. Addressing these underlying factors could
lead to resumption of treatment although in some cases the patients resumed treatment due to
deteriorating health.
“There's a girl who. . .has been on treatment for some time but her viral load was high, so
when I tried talking to her she was like "ah aah [No!]! Don’t tell me anything, I know every-
thing, I’ve decided I’m not taking [the drugs]”.By the way she came today I was surprised!. . .
when they asked her about her drugs she was like “I felt like I was tired of the drugs, so I needed
a break”. Sometimes adolescents they give themselves breaks. . .for like 3 months but when he
becomes sick, very sick, he comes back and says, “Now I want medicine”. It’s like they want to
first see what will happen when [on] a break”.
(Expert client-1)
Social-level factors. Delays in disclosing HIV status to perinatally infected children
prior to adolescence were common and could lead to non-adherence. In accordance with gov-
ernment regulation [30],it is the duty of the caretakers to disclose to their children, but they
were reluctant and cited barriers such as fear of being blamed for the infection, fear of unin-
tended disclosure of the parent HIV status by the child, fear of anticipated negative reactions
and concern for lack of cognitive ability of the child to comprehend the implications of the dis-
ease on their health. Due to this, caretakers would sometimes lie to their children about their
condition indicating that they were suffering from other chronic diseases like asthma or can-
cer. The concealment of status by implicating other diseases could however impact on the
adherence of the adolescents as it foils the understanding of the importance of adherence and
subsequent consequences, which are specific to HIV treatment. Moreover this could result in
anger and depression when the adolescents become aware of their condition. Health-care pro-
viders could at times be obligated to assist with disclosure mainly when it was imperative for
the child to know their status for example during adherence support at treatment failure or
treatment switch which was done as a means of averting further failures.
“This time we had a very strict doctor whom they found [during clinic visit]. . .she said “You
must disclose. . .because the boy is now 15 years and he is already on second-line
[treatment]. . .So, the doctor took her [guardian] to the counselor by force, and they made her
to disclose”
(Pharmacist-1)
Participants also noted that delays in disclosure were partly due to lack of supportive mech-
anisms to assist caretakers with disclosure.
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“Caretakers can manage when they are prepared on time about disclosure. Usually they are
stuck when you tell them [abruptly] that they need to tell the child. They are not prepared on
how [to go about it]?”
(Counselor-3)
It was also noted that the lack of support for disclosure could result with poor or partial dis-
closures where children knew about their HIV status but did not fully comprehend the impli-
cations of the disease. Late or poorly disclosed adolescents were likely to stop treatment, react
negatively to their caretakers and sometimes deny their HIV status.
Diminishing or lack of family support: Adolescents living with biological parents were
perceived to have better adherence compared to those living with caretakers. The latter were
reported to lack support for food, transport, medication reminders, and accompaniment by
caretakers during clinic visits. Some adolescents also reported that the caretakers denied them
education support on the misconception that they would die soon. However, as the adolescents
grow older the need to be independent as well as other structural barriers could result with
diminishing influence of the parents on the adolescent’s adherence behaviour or support.
“I’m asking [the mother] about so and so, she says "his drugs are at home" So the boy would
take [a few] tin[s], if he is dispensed with 3-months supply on 2nd line, he would take 2 tins,
leave the 4 at home. Then the mother would not bother, how comes, its long since he left his
medicine. You would call her and she says "so and so took medicine, some is still at home". Till
one time I told the woman that you carry all whatever you have at home [and bring to the
clinic], she carried tins and tins and returned them”
(Counselor- 1)
Perceived and experienced stigma in boarding schools: Adherence among students in
boarding schools was reported to be poor with the majority already being on second-line treat-
ment. Poor adherence was linked to stigma, and this was influenced by where and how the stu-
dents take their medication. Two groups emerged in the discussion: students who keep their
own medication in the dormitories and those who keep them with the school nurse. Keeping
drugs with the school nurse was reported to be beneficial due to likely reminders, close moni-
toring and easiness in getting permission for clinic visits. The preference to remain with the
drugs was however due to having not disclosed to the school administration, the desire to be
independent and fear of involuntary disclosure by the teachers or nurse to fellow students.
Moreover, prevention messages such as ‘AIDS Kills’ placed in most schools also inadvertently
stigmatized the infected students making it difficult for them to disclose.
Students keeping their own medication were said to face lack of privacy, anticipated (per-
ceived) and enacted (experienced) stigma from peers and they also sometimes failed to access
medication from the dormitories on time.
“There is a girl we lost, she passed away, she was 18. . . she had [experienced] stigma at school
because they came across her drugs in her suitcase, and they pulled them out and they put
them there and put her [medical] card on her bed and she was a head-girl and that killed her
[spirit]! She had to switch school. Most of them you get these calls, when they are saying they
have found out, you see, so she had to switch out schools”
(Counselor-3)
However, those keeping their medication with the school nurse also reported facing stigma
emerging from their peers who persistently inquire of their frequent visits to the infirmary.
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Moreover these students could also experience stigma arising from inadvertent disclosures by
the school nurse or administration.
“In the first school I disclosed. . .. but our nurse discriminated me. . .whenever the time of [taking]
drugs approached she could come in the class [and say], "you don’t know that you have to take
your drugs? Come and take your drugs" while all other students are there, [listening]. . . So they
[other students] used to inquire what drugs do you take, the nurse is [always asking]. . ."you
know you have your problem come and take your drugs ah". . .If you don’t want you will die" ah,
while other people are listening so [you get such] nicknames, “Mr. drugs, that is madam drugs”
(Expert client-2)
Health-care level factors. Declining or lack of clinic support: Most ALWHA at the
study facilities were reported to have been infected through vertical transmission and had
started ART early in life at the pediatric clinic. At 18 years of age they are expected to transition
to the adult-based care. Transitioning was however a challenge due to difficulties in integrating
with adult patients, reduced attention from health-care providers, long waiting hours, lack of
medicine for treatment of other ailments and a general sense of abandonment from health
care workers. Subsequently some of the adolescents would be lost-to-follow up.
“When we would transit them to adult [clinics], some of them would fail to come to pick their
drugs, they were not getting the attention they were getting in the pediatric [section], because
in pediatric, they are few [in numbers] and we try to know them personally”
(Pharmacist-1)
Although most participants expressed the importance of peer group support across all
patients, it was noted that a decline in funding had either resulted with fewer activities or the
complete phasing-out of these groups. The peer groups were reported to have served a pivotal
role in providing an avenue for strengthening adherence, dealing with emerging challenges,
providing motivation from peers and HIV-infected role models. Moreover, they also served as
platform for social networking, where participants would get potential life partners. The subse-
quent decline of these groups was reported to be have impacted especially the adolescents with
some of them opting out of care.
“Other challenges are the lack of peer groups and activities for adolescents. We used to have
them but because of funding they stopped. And some adolescents dropped off after these activi-
ties and some even died. They had a strong belonging to these groups”
(Counselor-6)
Moreover, while it was noted that adolescents were a group in need of more counseling,
this was hindered by a shortage of counselors. Frequent transfers of health-care providers due
to shortage in staff also posed a problem to the adolescents who found it a challenge to confide
and discuss freely about their health with new health-care providers. The use of social media
coordinated by the clinic was a notably noble alternative, which was used both socially and for-
mally to facilitate health-care providers and peer-peer counseling but was said to lack sufficient
participation from health-care providers.
“And another thing is all about our social network pages, especially the Facebook ones. We
need more counselors there. . .one can post via a friend so that others can know how to handle
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the problem but you fail to get even a counselor who can comment on the post or give advice
on the post”
(Expert client-2)
Barriers specific to adults
Individual-level factors. Temporary migrants and challenges with treatment access:
Mobile persons especially those travelling temporarily to nearby countries for business com-
prised a substantial majority of patients and they had notably poor appointment keeping and
drug pickups. Reasons given included lack of funds to cover for transport costs, perceived
feeling of wellness hence prioritizing business to drug refill visits, desire to match clinic visits
with trips for replenishing business stocks, and political conflicts in the host countries (mainly
Southern Sudan and Congo), which affected their travel.
“I’ve had experiences of people saying that they travelled to Juba [South Sudan]. . .they go
there for business. . .hoping to come back like after 3 months and the majority of them were
complaining of this recent war that was in Juba, they could not make it. . .others talk about
transport, they didn’t get enough money to come back [for drug refills] . . . then others talk of
no proper health facility elsewhere that could give them drugs, otherwise they would have con-
tinued taking HAART. . .others would point-blank tell you they were not feeling ill, health-
wise they were feeling ok, and since they were doing their business they decided to continue
[with] their business”.
(Counselor-4)
Other mobile populations included commercial sex workers, truck drivers, persons relocat-
ing to the villages for farming, and temporary emigrants. As a way of supporting these patients,
they were supplied with drugs for 6–12 months instead of the custom 3 months so as to mini-
mize on the number of drug-refill visits. Relatives or friends could also pick up drugs periodi-
cally on behalf of the patients but they would still be required to visit the clinics for blood tests at
least once or twice a year. Despite these interventions, some clients still had poor appointment
keeping prompting the health-care providers to encourage them to transfer to near-by facilities.
Some were however reluctant to transfer-out citing poor standards in other facilities. Some
migrants also reported reluctance by some of the host countries to provide them with ART.
Common barriers
Individual-level factors. Disclosure in intimate relationships: New challenges with dis-
closure were cited when engaging in romantic relationships leading to compromises in adher-
ence and potentially fuelling new infections. In adults, non-disclosure was linked to avoiding
marital conflicts, fears of losing the partner or/and financial support. Adolescents generally
lacked the skills to disclose and also feared losing their partner.
“In young adults, there are those getting boyfriends and girlfriends. They don’t disclose, and
that is what prevents them from taking the drugs. They feel ashamed and don’t want to lose
their partners”
(Expert client-3)
While support on disclosure was offered at the clinic, some health-care providers acknowl-
edged their own bias when counseling discordant couples because they did not approve such
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relationships. This in turn could lead to the clients not to seek for disclosure support in subse-
quent times.
“They will tell you, when we take these partners to the hospital. . .. they are quick to judge you,
you who is positive and yet you have brought in your partner really for testing. So they don’t
help them and they end up breaking up instead. They don’t support them into this relationship
and guide them on what to do. Instead they say heey! Trouble! So they separate them. So [they]
are stuck with their relationships, they can’t come out open, [they have questions] who is going
to support [me]. . . where should I go for counseling anyway? Because we are already biased”
(Counselor-03)
Health-care level factors. Treatment-related factors: Treatment side effects were also a
concern for long-term treated patients in particular those arising after switch to second-line
regimens. In adolescents this was said to result with re-emergence of stigma due to changes
in body fat distribution from lopinavir-based treatment, and yellow eyes (jaundice) from
atazanavir.
“We have many people who were changed to second-line, they were fat but now they are small.
And they ask the doctor's why? Does ‘lopinavir’ takes off the kilograms. . .they fail to adhere
whenever they see they have lost weight, they are looking bad, it seems as if ‘lopinavir’ is the
cause”
(Expert client-2)
There were also challenges with drug supply logistics where separate pills were supplied for
use by patients on fixed dose combinations (FDC). Moreover there were reports where facili-
ties were supplied with pediatric formulations involving multiple low milligram tablets, for use
by adults thereby increasing the pill burden.
“They send pediatric drugs for use in managing adults. So what we do, if the person has been
taking like one pill, she will take 3 or 4, to make an adult dose. It is a challenge, which increases
on client's pill burden”
(Counselor-8)
Moreover, adults also expressed a dislike of the sweet taste of pediatric drugs. In addition,
facilities reported being supplied with drug of different brands, some that had bitter taste
(uncoated drugs) and sometimes with varying colors and sizes. This was reported to confuse
the patients and affect their adherence especially when they were given the bitter drugs. There
were also claims of emerging side effects associated with change of drug brands.
“When we change from one company to another, some do experience some abnormal side-
effects and they always say: “when I was taking the other type I didn’t have any problem but
this time. . .”. Before we used to say that maybe they are used to this type of drug, but it does
really affect them. When you change them and put them to a previous one, the complaints do
go away.”
(Pharmacist-2)
Although there were no cases of drug stock-outs, there were reports of insufficient supply
of drugs or those with shorter expiration period, which necessitated more frequent drug refill
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visits. There was also a limited supply of third-line drugs, which was mainly available to
patients enrolled in medical research.
Staff shortages and missed counseling opportunities: Staff shortage leading to increased
workload and long waiting times resulted in missed opportunities for adequately counseling
the patients on vital information such as interpretation of laboratory test results. This could
lead to misconceptions with some patients inferring that an undetectable viral load implied
that they had been cured of the disease.
““So when [viral-load test] results were undetected, the person [clinician] would say that
‘akauka takalabika’ directly translating into the virus is invisible, so the patients would take it
as gospel truth [or]. . .they say ‘akauka tekalio’, meaning the virus is not there. . .. The health
worker should explain to those patients: last time we tested your viral load is undetectable, it
doesn't mean you are healed, it simply means that you are taking your drugs well and the
virus has just slept so you have to keep taking drugs so that the virus keeps sleeping. When you
stop, it wakes up. But most of them don't get that explanation”.
(FGD-2)
Discussion
Our study highlights pertinent insights into long-term ART adherence further distinguishing
between adults and perinatally infected adolescents. In adults, a return to health with resump-
tion of social and economic activities resulted in new dilemmas, potentially affecting their
adherence. In adolescents, the challenges in adherence were mainly related to stigma, disclo-
sure and declining clinic support.
Mobility and adherence in adults
Emerging challenges to adherence with treatment progression in adults identified in previous
studies suggest differences between early and long-term treated patients [10,14,31–33]. These
studies have shown changes in disease perceptions, non-disclosure in intimate relationships,
poor adherence to counselors’ instructions and re-emerging and persisting stigma as key chal-
lenges [10,14,31,33]. In our study, we further highlight challenges associated with mobile
groups especially temporary business migrants as they strive for social and economic improve-
ment. Although studies have documented the challenges faced by long-term migrants in
accessing HIV care [34], there is still limited information on circular migrants, defined origi-
nally by Zelinsky as short-term, repetitive, or cyclical [35], which encompasses the temporary
business migrants. The initial impediments to engagement in care and early adherence such as
lack of transport and proper health care services [26,27] re-emerged in these long-term treated
migrants, and were linked to a reluctance to transfer-out from their home facilities. In our
study sites, preferential supply of treatment for longer duration as well as allowing treatment
partners to pick-up drugs, were strategies that helped to maintain these patients on treatment.
The preference to further transfer patients to closer facilities was however a challenge citing
the reluctance by the host country to provide treatment to migrants. This is contrary to the rec-
ommendations by the ‘Global commission of HIV and the law’, directing that migrants be
accorded equal treatment as citizens in matters relating to HIV[36].
Stigma and ALWHA
As with previous studies, stigma was reported to impact on ART adherence especially among
adolescents in boarding schools [20,23,37,38]. These findings corroborate other studies
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reporting the challenges faced by ALWHA in schools including discrimination from their
peers and educators suggesting an increasing need for sensitization and training on their
rights and special needs in school settings [23,38]. In addition, there is a need for a balanced
approach in the design of HIV prevention messages in schools as the current ones such as
‘AIDS kills’ are discriminatory and further prevents ALWHA from disclosing and seeking sup-
port from either their peers or the school authorities.
Stigma among ALWHA was also associated with treatment side effects in particular visible
body changes such as lipodystrophy [39] and ‘yellow eyes’ [40] from atazanavir. As adolescents
are in particular careful about their physiques, it would be vital for treatment programs to con-
sider implementing a personalized treatment management approach including switching to
less toxic regimens once the patients have achieved viral suppression [41].
Lack or declining clinic support for ALWHA
The pivotal role of health-care providers and the clinic environment to ALWHA is well
known, with various studies showing the need for supportive early disclosure to caretakers
[42–44], provision of adolescent friendly services [45], role of peer groups [20,45,46] and
support for gradual transition to adult based care [45,46]. Despite this information, lack of
clear guidelines and support was associated to late, incomplete and poor disclosures by care-
takers and the subsequent decline in adherence [42]. Moreover, the need for gradual transi-
tion to adult-based care was a pertinent issue among adolescents in these facilities. Although
guidance for transition exist in developed countries, there is little support for adaptation and
implementation in sub-Saharan African settings [47]. Moreover the decline in funds leading
to the phase-out of peer-peer support and the lack of adolescent-friendly counselors impacts
negatively among the adolescents whose identity is strongly molded through the interactions
within the clinic environment [48]. It is worth noting that most vertically infected adoles-
cents are also orphaned and depend more on the close ties formed at the clinic for support
and empowerment against the various challenges inherent in the community [23]. These
findings continue to demonstrate the need for increased support of this group in the wake of
increasing deaths of ALWHA in sub-Saharan Africa [16]. Alternative use of social media was
seen as a platform to support adherence and cohesion among ALWHA. However, formal
integration into existing health systems, coupled with sensitization and training of health-
workers is needed to promote the use of these potential m-health tools in fostering adherence
counseling in these settings.
Challenges with drug supply logistics and influence on adherence
Apart from counseling, erratic drug supply logistics were also reported in these settings and in
particular influenced adherence among patients on long-term treatment. This suggests the
need for instituting quality systems to ensure continuous supply of appropriate regimen and
formulations, prevent supply of uncoated bitter pills, and ensure sufficient communication to
patients concerning the drug characteristics whenever there is a change in brand.
Study limitations
There are some study limitations. First, we mainly included the views and experiences of
health-care workers and expert clients and we may have missed other pertinent information
from patients, including adolescents. The study had been specifically designed to address the
barriers of long-term adherence based on the experience of health-care workers. The inclusion
of health-care providers was based on the premise of the in-depth information they possess
based on the nature of their interaction with HIV patients [49] and the additional advantage in
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their understanding of the health-care system. Our further inclusion of expert clients including
adolescents provided crucial information to the study because of their a) Interactions with the
patients at a more personal level: because of their own personal experiences with the disease
and treatment, expert patients are viewed to be more relatable and empathetic to the challenges
experience by the patients. This was vital among the adolescents who sometimes perceive the
adult clinicians as being insensitive to their needs. The expert clients also have closer relation-
ship with the patients, sometimes even visiting them at their homes to help address some of
the difficulties they face. b) their own personal experience: In addition to the experience they
have with the patients, the expert clients also shared their own experiences on the challenges
they face with long-term ART adherence c) their view from both the perspective of the patient
as well as from the health-care perspective: The information provided by the expert clients also
reflects a balanced view of the barriers related to the health-care system owing to the fact that
they serve as health-care workers and are also patients in the same facilities.
Second, our study was carried out in regional facilities and may underestimate the broader
view especially from lower-level health facilities.
Conclusion
Successful adherence among long-term treated patients in these setting is hampered by life-
course events and is especially challenging among adolescents. There is thus need for programs
to tailor adherence interventions to the emerging needs including support for disclosure to
intimate partners and ways of ensuring continuity of treatment among temporary economic
migrants. Moreover, programs should endeavor to support ALWHA in particular by offering
support to caretakers for early and gradual disclosure of HIV status, supportive gradual transi-
tion to adult-based care as well as maintaining functional peer-support groups. Lastly there is
need to train and sensitize educators and students against discrimination of ALWHA as well
as empowering the infected children to cope with stigma in boarding schools.
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